For example, the sequential genetic mutation of TP53 followed by MSH2 (TP53~MSH2) was observed in hypermutated cancers, but the mutation of MSH2 followed by TP53 (MSH2~TP53) was not (Figure 6B). This evidence concerns the gene MSH2 and cancer.